EspeRare CEO: Proceeds From Dermelix Co-Development Pact To Fund Genetic Pre-Natal Pipeline R&D

Small shoes for the unborn baby in the belly of pregnant woman
DMX-101 has the potential to correct a genetic disease before birth • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business